Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-83,700
Closed -$27M 1357
2024
Q3
$27M Sell
83,700
-18,800
-18% -$6.15M 0.06% 199
2024
Q2
$32M Buy
102,500
+36,700
+56% +$10.8M 0.07% 163
2024
Q1
$18.7M Sell
65,800
-42,900
-39% -$12.6M 0.03% 285
2023
Q4
$31.3M Sell
108,700
-10,800
-9% -$2.94M 0.05% 215
2023
Q3
$32.1M Buy
+119,500
New +$29.8M 0.06% 193

Other funds holding AMGN

GTS Securities's AMGN Position: Q2 2026 in Review

GTS Securities reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $22.3K and leaving 4,988 shares worth $1.81M. The position accounts for 0.04% of the portfolio, ranked #269.

GTS Securities first reported a position in AMGN in Q2 2023 and has held it in 11 quarters since. The position peaked at $3.95M in Q3 2024. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GTS Securities held 4,988 shares of Amgen worth $1.81M as of Q2 2026.
  • GTS Securities sold 65 Amgen shares in Q2 2026, an estimated $22.3K.
  • Amgen made up 0.04% of GTS Securities's portfolio in Q2 2026, its #269 holding.
  • GTS Securities first reported a position in Amgen in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's Amgen position peaked at $3.95M in Q3 2024.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.